Did you know each electric car battery requires 220 pounds of graphite – more than lithium, copper, or aluminum? China controls more than 90% of this vital ingredient. But the U.S. just classified graphite as "essential for America's National Defense"... and one little-known company is looking to win big in the energy war with China.

Find Out How Investors Can Benefit From the Energy

VRTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $75,733,606.90

Vertex Pharmaceuticals Insider Trading History Chart

Vertex Pharmaceuticals Share Price & Price History

^$317.60

▼ -3.77 (-1.17%)

As of 12/5/2022 01:00 AM ET

Days: 30 | 90 | 365

Are Investors Returning to the Small-Cap Uranium Sector?

From Investing Trends | Ad

Back in the early 2000's, small-cap Paladin Energy was the darling of the last uranium boom when it shot up from ten cents to over nine dollars.

Today's uranium supply/demand imbalance has a lot in common with the last market cycle. Combined with the energy crisis and "green revolution," this could be setting the stage for the next uranium boom.

Get the Full Story on Uranium Opportunities Here

Vertex Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/7/2022	David Altshuler	EVP	Sell	1,303	$303.04	$394,861.12	36,077
10/24/2022	Sangeeta N Bhatia	Director	Sell	621	$310.00	$192,510.00	4,040
10/18/2022	Bastiano Sanna	EVP	Sell	1,791	$300.31	$537,855.21	39,192
8/15/2022	Joy Liu	SVP	Sell	3,747	$303.90	$1,138,713.30	9,605
8/15/2022	Reshma Kewalramani	CEO	Sell	11,689	$305.06	$3,565,846.34	99,598
8/15/2022	Stuart A. Arbuckle	COO	Sell	22,173	$303.93	$6,739,039.89	45,278
8/9/2022	Joy Liu	SVP	Sell	946	$300.00	$283,800.00	13,388
8/9/2022	Ourania Tatsis	EVP	Sell	1,400	$298.97	$418,558.00	46,090
8/9/2022	Stuart A. Arbuckle	COO	Sell	5,690	$300.67	$1,710,812.30	60,996
8/8/2022	Sangeeta N Bhatia	Director	Sell	621	$293.03	$181,971.63	4,661
7/29/2022	Sangeeta N Bhatia	Director	Sell	621	$278.77	$173,116.17	5,282
7/25/2022	Jeffrey M. Leiden	Chairman	Sell	132,079	$281.38	$37,164,389.02	2,423
7/19/2022	David Altshuler	EVP	Sell	17,865	$288.65	$5,156,732.25	36,077
6/24/2022	Reshma Kewalramani	CEO	Sell	11,689	$291.30	$3,405,005.70	111,153
5/4/2022	Bastiano Sanna	EVP	Sell	36	$275.09	$9,903.24	41,660
5/2/2022	Bastiano Sanna	EVP	Sell	320	$259.16	$82,931.20	41,696
5/2/2022	Charles F. Wagner, Jr.	CFO	Sell	343	$258.83	$88,778.69	42,730
5/2/2022	Sangeeta N Bhatia	Director	Sell	737	$258.94	$190,838.78	5,903
5/2/2022	Stuart A. Arbuckle	COO	Sell	306	$263.98	$80,777.88	64,760
4/29/2022	Joy Liu	SVP	Sell	120	$275.41	$33,049.20	14,334
4/25/2022	Kristen Ambrose	CAO	Sell	327	$269.55	$88,142.85	3,496
4/18/2022	Yuchun Lee	Director	Sell	2,000	$284.23	$568,460.00	1,875
4/13/2022	Jeffrey M. Leiden	Chairman	Sell	15,789	$289.04	$4,563,652.56	74,160
4/13/2022	Yuchun Lee	Director	Sell	2,000	$287.50	$575,000.00	1,875
4/11/2022	Yuchun Lee	Director	Sell	2,000	$280.30	$560,600.00	1,875
4/7/2022	Bastiano Sanna	EVP	Sell	561	$276.18	$154,936.98	42,782
4/7/2022	Yuchun Lee	Director	Sell	2,000	$274.86	$549,720.00	1,099
4/4/2022	Bastiano Sanna	EVP	Sell	562	$267.71	$150,453.02	43,343
4/4/2022	Yuchun Lee	Director	Sell	2,000	$267.72	$535,440.00	1,875
4/1/2022	Charles F. Wagner, Jr.	CFO	Sell	2,582	$264.76	$683,610.32	43,620
3/31/2022	Margaret G. McGlynn	Director	Sell	5,000	$262.27	$1,311,350.00	1,099
3/17/2022	Charles F. Wagner, Jr.	CFO	Sell	3,171	$250.15	$793,225.65
3/17/2022	Ourania Tatsis	EVP	Sell	2,833	$250.11	$708,561.63
2/25/2022	Ourania Tatsis	EVP	Sell	325	$230.95	$75,058.75
2/18/2022	Ourania Tatsis	EVP	Sell	519	$231.00	$119,889.00
2/11/2022	David Altshuler	EVP	Sell	2,297	$235.02	$539,840.94
2/2/2022	Bastiano Sanna	EVP	Sell	1,040	$250.98	$261,019.20
2/2/2022	Charles F. Wagner, Jr.	CFO	Sell	2,944	$250.07	$736,206.08
1/28/2022	Margaret G. McGlynn	Director	Sell	5,000	$241.79	$1,208,950.00
11/15/2021	Amit Sachdev	EVP	Sell	51	$187.19	$9,546.69
11/15/2021	Stuart A. Arbuckle	COO	Sell	3	$187.26	$561.78
8/19/2021	Reshma Kewalramani	CEO	Buy	10,000	$195.65	$1,956,500.00	69,511
6/2/2021	Sangeeta N. Bhatia	Director	Sell	559	$209.69	$117,216.71	5,465
5/3/2021	Bastiano Sanna	EVP	Sell	960	$218.43	$209,692.80	35,068
4/27/2021	Amit Sachdev	EVP	Sell	3,884	$216.06	$839,177.04	44,017
4/5/2021	Bastiano Sanna	EVP	Sell	1,686	$214.14	$361,040.04	36,223
2/11/2021	Bastiano Sanna	EVP	Sell	1,686	$210.56	$355,004.16	39,081
2/11/2021	Paul M. Silva	CAO	Sell	1,498	$210.57	$315,433.86	24,073
2/5/2021	Michael Parini	EVP	Sell	1,930	$215.00	$414,950.00	59,157
2/3/2021	Michael Parini	EVP	Sell	400	$216.56	$86,624.00	35,276
11/10/2020	Bruce I. Sachs	Director	Buy	15,000	$217.36	$3,260,400.00	18,035
11/3/2020	Stuart A. Arbuckle	EVP	Sell	1,553	$211.92	$329,111.76	36,732
10/5/2020	Sangeeta N Bhatia	Director	Sell	10,516	$266.79	$2,805,563.64	14,424
8/3/2020	Amit Sachdev	EVP	Sell	1,941	$278.28	$540,141.48	37,044
7/13/2020	Michael Parini	EVP	Sell	2,125	$292.05	$620,606.25	28,963
7/13/2020	Paul M. Silva	SVP	Sell	860	$292.03	$251,145.80	15,792
7/10/2020	Charles F. Wagner, Jr.	CFO	Sell	700	$293.15	$205,205.00	16,786
7/7/2020	Stuart A. Arbuckle	EVP	Sell	2,786	$300.00	$835,800.00	36,743
6/30/2020	Jeffrey M. Leiden	Chairman	Sell	32,792	$286.15	$9,383,430.80	29,252
5/12/2020	Jeffrey M. Leiden	Chairman	Sell	94,370	$283.47	$26,751,063.90	65,036
5/11/2020	Amit Sachdev	EVP	Sell	10,665	$282.61	$3,014,035.65	45,768
5/7/2020	Bruce I. Sachs	Director	Sell	45,000	$269.80	$12,141,000.00	33,710
5/6/2020	Paul M. Silva	SVP	Sell	1,076	$272.74	$293,468.24	15,397
5/5/2020	Amit Sachdev	EVP	Sell	13,356	$270.01	$3,606,253.56	67,603
5/5/2020	Jeffrey M. Leiden	Chairman	Sell	94,372	$269.94	$25,474,777.68	76,707
5/4/2020	Paul M. Silva	SVP	Sell	809	$260.87	$211,043.83	15,741
4/29/2020	Michael Parini	EVP	Sell	2,125	$254.95	$541,768.75	28,963
4/27/2020	Yuchun Lee	Director	Sell	2,000	$271.21	$542,420.00	3,875
4/24/2020	Yuchun Lee	Director	Sell	2,000	$268.14	$536,280.00	3,875
4/22/2020	Yuchun Lee	Director	Sell	2,000	$267.88	$535,760.00	3,875
4/20/2020	Yuchun Lee	Director	Sell	2,000	$273.16	$546,320.00	3,875
4/13/2020	Paul M. Silva	SVP	Sell	859	$248.72	$213,650.48	15,791
4/6/2020	Paul M. Silva	SVP	Sell	4,891	$255.57	$1,249,992.87	19,823
2/25/2020	Amit Sachdev	EVP	Sell	3,376	$233.53	$788,397.28	36,291
2/25/2020	Jeffrey M. Leiden	CEO	Sell	10,550	$233.46	$2,463,003.00	103,131
2/25/2020	Ourania Tatsis	SVP	Sell	1,296	$233.17	$302,188.32	14,034
2/25/2020	Reshma Kewalramani	CMO	Sell	3,634	$233.45	$848,357.30	30,260
2/18/2020	Amit Sachdev	EVP	Sell	3,489	$243.56	$849,780.84	42,936
2/18/2020	Jeffrey M. Leiden	CEO	Sell	11,685	$243.52	$2,845,531.20	123,226
2/18/2020	Ourania Tatsis	SVP	Sell	1,279	$243.62	$311,589.98	16,349
2/18/2020	Reshma Kewalramani	CMO	Sell	1,183	$243.51	$288,072.33	34,341
2/7/2020	Yuchun Lee	Director	Sell	2,000	$237.82	$475,640.00	3,875
2/4/2020	Yuchun Lee	Director	Sell	2,000	$238.84	$477,680.00	3,875
1/22/2020	Michael Parini	EVP	Sell	1	$237.50	$237.50	35,004
1/16/2020	Amit Sachdev	EVP	Sell	5,000	$235.00	$1,175,000.00	41,190
1/13/2020	Michael Parini	EVP	Sell	2,125	$226.78	$481,907.50	37,128
1/13/2020	Paul M. Silva	SVP	Sell	860	$229.38	$197,266.80	18,619
1/8/2020	Amit Sachdev	EVP	Sell	5,000	$230.00	$1,150,000.00	41,190
1/8/2020	Paul M. Silva	SVP	Sell	13,750	$231.89	$3,188,487.50	31,509
1/6/2020	Michael Parini	EVP	Sell	4,250	$222.00	$943,500.00	39,253
1/2/2020	Paul M. Silva	SVP	Sell	25,630	$218.92	$5,610,919.60	34,517
1/2/2020	William D Young	Director	Sell	20,000	$218.93	$4,378,600.00	29,311
12/9/2019	Amit Sachdev	EVP	Sell	5,000	$225.00	$1,125,000.00	38,416

Are Investors Returning to the Small-Cap Uranium Sector?

From Investing Trends | Ad

Get the Full Story on Uranium Opportunities Here

SEC Filings (Institutional Ownership Changes) for Vertex Pharmaceuticals (NASDAQ:VRTX)

91.33% of Vertex Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vertex Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/5/2022	Centaurus Financial Inc.	456	$0.13M	0.0%	+27.4%	0.000%
12/1/2022	Robeco Institutional Asset Management B.V.	339,030	$98.16M	0.3%	+33.5%	0.132%
11/23/2022	Toroso Investments LLC	25,029	$7.25M	0.3%	+49.4%	0.010%
11/22/2022	CVA Family Office LLC	275	$80K	0.0%	+17.0%	0.000%
11/22/2022	IHT Wealth Management LLC	2,225	$0.64M	0.0%	N/A	0.001%
11/22/2022	B. Riley Wealth Advisors Inc.	16,747	$4.85M	0.1%	+6.7%	0.007%
11/22/2022	Teachers Retirement System of The State of Kentucky	149,248	$43.21M	0.5%	N/A	0.058%
11/21/2022	FourThought Financial LLC	1,670	$0.48M	0.1%	+26.5%	0.001%
11/21/2022	California State Teachers Retirement System	430,019	$124.51M	0.2%	-0.8%	0.168%
11/18/2022	Power Corp of Canada	1,043	$0.30M	0.0%	N/A	0.000%
11/18/2022	Industrial Alliance Investment Management Inc.	62,748	$18.17M	0.5%	+27.2%	0.024%
11/18/2022	National Pension Service	405,860	$118.84M	0.2%	+0.9%	0.158%
11/17/2022	CENTRAL TRUST Co	11,040	$3.20M	0.1%	-7.5%	0.004%
11/17/2022	M&T Bank Corp	15,785	$4.57M	0.0%	+12.9%	0.006%
11/17/2022	Provident Investment Management Inc.	162,027	$46.91M	6.0%	-4.3%	0.063%
11/16/2022	Tealwood Asset Management Inc.	4,569	$1.32M	0.7%	-65.8%	0.002%
11/16/2022	Kayne Anderson Rudnick Investment Management LLC	15,732	$4.56M	0.0%	+157,220.0%	0.006%
11/16/2022	Glenmede Trust Co. NA	159,723	$46.25M	0.3%	+1.4%	0.062%
11/16/2022	Captrust Financial Advisors	19,520	$5.65M	0.0%	-4.5%	0.008%
11/16/2022	Kentucky Retirement Systems Insurance Trust Fund	9,191	$2.66M	0.2%	+5.2%	0.004%
11/16/2022	Kentucky Retirement Systems	20,075	$5.81M	0.2%	+5.8%	0.008%
11/16/2022	AIMZ Investment Advisors LLC	23,080	$6.68M	3.4%	-0.3%	0.009%
11/16/2022	Alpha Paradigm Partners LLC	3,554	$1.03M	0.4%	N/A	0.001%
11/16/2022	Ascent Group LLC	4,294	$1.34M	0.2%	+287.5%	0.002%
11/16/2022	Baird Financial Group Inc.	56,152	$16.26M	0.0%	+1.3%	0.022%
11/16/2022	CIBC Private Wealth Group LLC	4,127	$1.20M	0.0%	-55.0%	0.002%
11/16/2022	Claraphi Advisory Network LLC	771	$0.22M	0.1%	-58.7%	0.000%
11/16/2022	Clearstead Advisors LLC	489	$0.14M	0.0%	+12,125.0%	0.000%
11/16/2022	Covington Capital Management	412	$0.12M	0.0%	-15.4%	0.000%
11/16/2022	CreativeOne Wealth LLC	3,105	$0.90M	0.1%	+284.3%	0.001%
11/16/2022	Fred Alger Management LLC	527,706	$152.79M	0.8%	+5.9%	0.206%
11/16/2022	Mather Group LLC.	2,781	$0.81M	0.0%	+9.1%	0.001%
11/16/2022	Meiji Yasuda Asset Management Co Ltd.	19,890	$5.76M	0.3%	-1.9%	0.008%
11/16/2022	Meiji Yasuda Life Insurance Co	7,959	$2.30M	0.1%	+26.4%	0.003%
11/16/2022	MidWestOne Financial Group Inc.	4,734	$1.37M	0.3%	-7.1%	0.002%
11/16/2022	Wealthsource Partners LLC	1,081	$0.31M	0.0%	+49.7%	0.000%
11/16/2022	Ashford Capital Management Inc.	6,743	$1.95M	0.3%	-26.7%	0.003%
11/15/2022	Neuberger Berman Group LLC	265,809	$76.97M	0.1%	-33.5%	0.104%
11/15/2022	Regal Investment Advisors LLC	5,691	$1.65M	0.2%	+8.8%	0.002%
11/15/2022	Alliancebernstein L.P.	9,145,516	$2.65B	1.3%	-1.7%	3.563%
11/15/2022	State Street Corp	12,294,791	$3.56B	0.2%	+0.3%	4.790%
11/15/2022	Northeast Financial Consultants Inc	5,913	$1.71M	0.1%	-10.7%	0.002%
11/15/2022	Public Employees Retirement System of Ohio	155,501	$45.02M	0.2%	+1.0%	0.061%
11/15/2022	Jacobs Levy Equity Management Inc.	201,674	$58.39M	0.5%	+44.6%	0.079%
11/15/2022	Public Employees Retirement Association of Colorado	452,718	$131.08M	0.8%	+0.5%	0.176%
11/15/2022	Railway Pension Investments Ltd	48,900	$14.16M	0.2%	+106.3%	0.019%
11/15/2022	Northwest Bancshares Inc.	21,584	$6.25M	1.5%	+0.2%	0.008%
11/15/2022	Colony Group LLC	86,226	$24.97M	0.4%	+16.7%	0.034%
11/15/2022	Mercer Global Advisors Inc. ADV	8,124	$2.35M	0.0%	-9.3%	0.003%
11/15/2022	Strategic Global Advisors LLC	8,976	$2.60M	0.4%	-2.7%	0.003%
11/15/2022	Summit Global Investments	73,008	$21.14M	2.0%	-9.7%	0.028%
11/15/2022	Thrivent Financial for Lutherans	95,314	$27.60M	0.1%	-8.0%	0.037%
11/15/2022	Two Sigma Advisers LP	23,000	$6.66M	0.0%	-6.9%	0.009%
11/15/2022	Trexquant Investment LP	29,180	$8.45M	0.3%	N/A	0.011%
11/15/2022	Trust Asset Management LLC	2,886	$0.84M	0.1%	+7.9%	0.001%
11/15/2022	UBS Asset Management Americas Inc.	3,158,692	$914.57M	0.5%	+1.2%	1.231%
11/15/2022	Unigestion Holding SA	97,065	$28.42M	1.7%	+2,062.8%	0.038%
11/15/2022	Utah Retirement Systems	45,848	$13.27M	0.2%	+0.6%	0.018%
11/15/2022	Vanguard Group Inc.	21,132,336	$6.12B	0.2%	+1.4%	8.233%
11/15/2022	Pathstone Family Office LLC	14,280	$4.14M	0.1%	+32.4%	0.006%
11/15/2022	Price T Rowe Associates Inc. MD	5,157,954	$1.49B	0.2%	+3.9%	2.009%
11/15/2022	Pura Vida Investments LLC	26,763	$7.75M	0.4%	+59.7%	0.010%
11/15/2022	Putnam Investments LLC	143,281	$41.49M	0.1%	-24.0%	0.056%
11/15/2022	Q3 Asset Management	943	$0.28M	0.2%	-22.9%	0.000%
11/15/2022	Koss Olinger Consulting LLC	6,853	$1.98M	0.3%	-2.1%	0.003%
11/15/2022	Lord Abbett & CO. LLC	554,586	$160.57M	0.6%	+4.1%	0.216%
11/15/2022	Laidlaw Wealth Management LLC	948	$0.27M	0.1%	+29.2%	0.000%
11/15/2022	Leelyn Smith LLC	816	$0.24M	0.1%	-69.1%	0.000%
11/15/2022	Lido Advisors LLC	15,998	$4.63M	0.1%	+285.8%	0.006%
11/15/2022	Livforsakringsbolaget Skandia Omsesidigt	15,787	$4.57M	0.6%	-13.7%	0.006%
11/15/2022	Marshall Wace LLP	273,852	$79.29M	0.2%	-30.0%	0.107%
11/15/2022	Martingale Asset Management L P	85,638	$24.80M	0.5%	+29.7%	0.033%
11/15/2022	Marvin & Palmer Associates Inc.	39,155	$11.34M	7.0%	-4.6%	0.015%
11/15/2022	EHP Funds Inc.	3,830	$1.11M	0.2%	N/A	0.001%
11/15/2022	Essex Investment Management Co. LLC	13,376	$3.87M	0.6%	-5.9%	0.005%
11/15/2022	ETF Managers Group LLC	5,571	$1.61M	0.1%	-10.6%	0.002%
11/15/2022	Evergreen Capital Management LLC	1,450	$0.42M	0.0%	+44.7%	0.001%
11/15/2022	Edgestream Partners L.P.	5,068	$1.47M	0.1%	+83.3%	0.002%
11/15/2022	Engineers Gate Manager LP	2,338	$0.68M	0.0%	-54.3%	0.001%
11/15/2022	Ensign Peak Advisors Inc	395,691	$114.57M	0.3%	+8.4%	0.154%
11/15/2022	Epoch Investment Partners Inc.	454,964	$131.73M	0.9%	-9.4%	0.177%
11/15/2022	Ethic Inc.	7,331	$2.12M	0.1%	+22.1%	0.003%
11/15/2022	Evercore Wealth Management LLC	1,644	$0.48M	0.0%	+3.1%	0.001%
11/15/2022	Federated Hermes Inc.	156,390	$45.28M	0.1%	-11.3%	0.061%
11/15/2022	First Manhattan Co.	1,550	$0.45M	0.0%	-11.4%	0.001%
11/15/2022	First Trust Advisors LP	360,892	$104.49M	0.1%	-64.9%	0.141%
11/15/2022	Financial Advocates Investment Management	12,405	$0.37M	0.0%	N/A	0.005%
11/15/2022	First Capital Advisors Group LLC.	705	$0.20M	0.2%	N/A	0.000%
11/15/2022	Formidable Asset Management LLC	4,693	$1.36M	0.3%	+2.3%	0.002%
11/15/2022	Baker Avenue Asset Management LP	1,719	$0.50M	0.0%	N/A	0.001%
11/15/2022	Bank of New York Mellon Corp	2,081,470	$602.67M	0.1%	-0.8%	0.811%
11/15/2022	Bellevue Group AG	1,158,126	$335.32M	4.8%	-1.5%	0.451%
11/15/2022	Belpointe Asset Management LLC	6,927	$2.01M	0.1%	+29.9%	0.003%
11/15/2022	BlackRock Inc.	25,243,060	$7.31B	0.2%	+0.4%	9.834%
11/15/2022	C M Bidwell & Associates Ltd.	295	$85K	0.1%	+2,850.0%	0.000%
11/15/2022	Caisse DE Depot ET Placement DU Quebec	1,085,220	$314.22M	0.9%	-15.2%	0.423%
11/15/2022	Capital International Ltd. CA	70,850	$20.51M	1.4%	+11.8%	0.028%
11/15/2022	Cary Street Partners Investment Advisory LLC	10,268	$2.97M	0.2%	N/A	0.004%
11/15/2022	Caxton Associates LP	5,058	$1.46M	0.2%	+353.6%	0.002%
11/15/2022	CI Investments Inc.	7,364	$2.13M	0.0%	+30.0%	0.003%

Data available starting January 2016

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation. Its pipeline includes VX-864 for the treatment of AAT deficiency, which is in Phase 2 clinical trial; VX-147 for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases which is in Phase 2 clinical trial; VX- 880, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-548, a NaV1.8 inhibitor for treatments of acute, neuropathic, musculoskeletal pain which is in Phase 2 clinical trial; and CTX001 for the treatment severe SCD and TDT which is in Phase 3 clinical trial. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. It has collaborations with Affinia Therapeutics, Inc.; Arbor Biotechnologies, Inc.; CRISPR Therapeutics AG.; Kymera Therapeutics, Inc.; Mammoth Biosciences, Inc.; Moderna, Inc.; Obsidian Therapeutics, Inc.; and Skyhawk Therapeutics, Inc.; as well as Ribometrix, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany, and X-Chem, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $317.60

$315.55

$319.69

50 Day Range

MA: $304.32

$276.78

$321.48

52 Week Range

Now: $317.60

$203.04

$323.61

Volume

790,972 shs

Average Volume

1,597,012 shs

Market Capitalization

$81.53 billion

P/E Ratio

25.05

Dividend Yield

N/A

Beta

0.43

Who are the company insiders with the largest holdings of Vertex Pharmaceuticals?: Vertex Pharmaceuticals' top insider shareholders include:
Reshma Kewalramani (CEO)
Jeffrey M Leiden (Chairman)
Stuart A Arbuckle (COO)
Michael Parini (EVP)
Ourania Tatsis (EVP)
Amit Sachdev (EVP)
Charles F Wagner Jr (CFO)
Bastiano Sanna (EVP)
David Altshuler (EVP)
Paul M Silva (CAO)
Joy Liu (SVP)
Sangeeta N Bhatia (Director)
Sangeeta N Bhatia (Director)
Kristen Ambrose (CAO)
Yuchun Lee (Director)
Margaret G Mcglynn (Director)
Learn More about top insider investors at Vertex Pharmaceuticals.
Who are the major institutional investors of Vertex Pharmaceuticals?: Vertex Pharmaceuticals' top institutional investors include:
BlackRock Inc. — 9.83%
Vanguard Group Inc. — 8.23%
State Street Corp — 4.79%
Alliancebernstein L.P. — 3.56%
Price T Rowe Associates Inc. MD — 2.01%
Jennison Associates LLC — 1.85%
Learn More about top institutional investors of Vertex Pharmaceuticals stock.
Which major investors are selling Vertex Pharmaceuticals stock?: Within the previous quarter, VRTX stock was sold by these institutional investors:
First Trust Advisors LP
Vaughan Nelson Investment Management L.P.
Lazard Asset Management LLC
Mayflower Financial Advisors LLC
ARK Investment Management LLC
Caisse DE Depot ET Placement DU Quebec
Armistice Capital LLC
Scout Investments Inc.
In the last year, company insiders that have sold Vertex Pharmaceuticals company stock include:
Reshma Kewalramani (CEO)
Jeffrey M Leiden (Chairman)
Stuart A Arbuckle (COO)
Michael Parini (EVP)
Ourania Tatsis (EVP)
Amit Sachdev (EVP)
Charles F Wagner Jr (CFO)
Bastiano Sanna (EVP)
David Altshuler (EVP)
Paul M Silva (CAO)
Joy Liu (SVP)
Sangeeta N Bhatia (Director)
Learn More investors selling Vertex Pharmaceuticals stock.
Which major investors are buying Vertex Pharmaceuticals stock?: During the previous quarter, VRTX stock was acquired by institutional investors including:
Jennison Associates LLC
Assetmark Inc.
Renaissance Technologies LLC
Great West Life Assurance Co. Can
Vanguard Group Inc.
Price T Rowe Associates Inc. MD
Teachers Retirement System of The State of Kentucky
Assenagon Asset Management S.A.

The Lithium "Lie"

From Investing Trends | Ad

Find Out How Investors Can Benefit From the Energy

VRTX Insider Trading

Vertex Pharmaceuticals Insider Trading History Chart

Vertex Pharmaceuticals Share Price & Price History

Vertex Pharmaceuticals Insider Trading History

SEC Filings (Institutional Ownership Changes) for Vertex Pharmaceuticals (NASDAQ:VRTX)

Institutional Buying and Selling by Quarter

Vertex Pharmaceuticals Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Vertex Pharmaceuticals?

Who are the major institutional investors of Vertex Pharmaceuticals?

Which major investors are selling Vertex Pharmaceuticals stock?

Which major investors are buying Vertex Pharmaceuticals stock?